Abstract

Correspondence on, "UBE2T is a diagnostic and prognostic biomarker for endometrial cancer".

Full Text

Published Version

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author

More From: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Paper Title
Journal
Date
Author
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature.
Siddharth Shah ... Brandon Lucke-Wold
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Siddharth Shah, et. al.Siddharth Shah ... Brandon Lucke-Wold
23 Dec 2024
Prognostic value of HER2 2+ expression in patients with TNBC receiving adjuvant capecitabine.
Tuğba Önder ... Ayşe Ocak Duran
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Tuğba Önder, et. al.Tuğba Önder ... Ayşe Ocak Duran
22 Dec 2024
The role of the CXCL12/CXCR4 axis in the immunotherapy of non-small cell lung cancer.
Jacobo Rogado ... Ramon Colomer
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Jacobo Rogado, et. al.Jacobo Rogado ... Ramon Colomer
21 Dec 2024
PSA bounce: understanding temporal fluctuations in prostate cancer after external radiotherapy.
Nicolas Feltes Benitez ... Esther Jovell-Fernandez
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Nicolas Feltes Benitez, et. al.Nicolas Feltes Benitez ... Esther Jovell-Fernandez
20 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.